CORT
Corcept Therapeutics Incorporated · Healthcare
Chief Development Officer William Guyer sold $1.6M of Corcept Therapeutics Incorporated
Sold$1,601,526
$80.08Price
20,000Shares
−94%Stake
What CORT did after the filing
- The stock from Thu, Dec 4 open, $84.35
- −58.2%
- S&P 500, same days
- −0.3%
Measured over 30 trading days, to the Jan 20 close.
Traded Tue, Dec 2. Filed Wed, Dec 3. Returns use the Dec 4 open and the Jan 20 close. Not investment advice.